Department of Nephrology, The First Hospital of Lanzhou University, Lanzhou, China.
Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China.
Am J Physiol Renal Physiol. 2024 Nov 1;327(5):F910-F929. doi: 10.1152/ajprenal.00409.2023. Epub 2024 Sep 12.
Renal ischemia-reperfusion injury (IRI) is a complex pathophysiological process and a major cause of delayed graft function (DGF) after transplantation. MicroRNA (miRNA) has important roles in the pathogenesis of IRI and may represent promising therapeutic targets for mitigating renal IRI. miRNA sequencing was performed to profile microRNA expression in mouse kidneys after cold storage and transplantation (CST). Lentivirus incorporating a miR-199a-5p modulator was injected into mouse kidney in situ before syngenetic transplantation and unilateral IRI to determine the effect of miR-199a-5p in vivo. miR-199a-5p mimic or inhibitor was transfected cultured tubular cells before ATP depletion recovery treatment to examine the role of miR-199a-5p in vitro. Sequencing data and microarray showed upregulation of miR-199a-5p in mice CST and human DGF samples. Lentivirus incorporating a miR-199a-5p mimic aggravated renal IRI, and protective effects were obtained with a miR-199a-5p inhibitor. Treatment with the miR-199a-5p inhibitor ameliorated graft function loss, tubular injury, and immune response after CST. In vitro experiments revealed exacerbation of mitochondria dysfunction upon ATP depletion and repletion model in the presence of the miR-199a-5p mimic, whereas dysfunction was attenuated when the miR-199a-5p inhibitor was applied. miR-199a-5p was shown to target A-kinase anchoring protein 1 (AKAP1) by double luciferase assay and miR-199a-5p activation reduced dynamin-related protein 1 (Drp1)-s637 phosphorylation and mitochondrial length. Overexpression of AKAP1 preserved Drp1-s637 phosphorylation and reduced mitochondrial fission. miR-199a-5p activation reduced AKAP1 expression, promoted Drp1-s637 dephosphorylation, aggravated the disruption of mitochondrial dynamics, and contributed to renal IRI. This study identifies miR-199a-5p as a key regulator in renal ischemia-reperfusion injury through microRNA sequencing in mouse models and human delayed graft function. miR-199a-5p worsens renal IRI by aggravating graft dysfunction, tubular injury, and immune response, while its inhibition shows protective effects. miR-199a-5p downregulates A-kinase anchoring protein 1 (AKAP1), reducing dynamin-related protein 1 (Drp1)-s637 phosphorylation, increasing mitochondrial fission, and causing dysfunction. Targeting the miR-199a-5p/AKAP1/Drp1 axis offers therapeutic potential for renal IRI, as AKAP1 overexpression preserves mitochondrial integrity by maintaining Drp1-s637 phosphorylation.
肾缺血再灌注损伤(IRI)是一个复杂的病理生理过程,也是移植后延迟移植物功能(DGF)的主要原因。微小 RNA(miRNA)在 IRI 的发病机制中具有重要作用,可能是减轻肾 IRI 的有前途的治疗靶点。进行 miRNA 测序以分析冷保存和移植(CST)后小鼠肾脏中 microRNA 的表达。在同基因移植和单侧 IRI 前,将携带 miR-199a-5p 调节剂的慢病毒注入小鼠肾原位,以确定 miR-199a-5p 在体内的作用。miR-199a-5p 模拟物或抑制剂在 ATP 耗竭恢复处理前转染培养的肾小管细胞,以研究 miR-199a-5p 在体外的作用。测序数据和微阵列显示 miR-199a-5p 在小鼠 CST 和人 DGF 样本中上调。携带 miR-199a-5p 模拟物的慢病毒加重了肾 IRI,而 miR-199a-5p 抑制剂则获得了保护作用。miR-199a-5p 抑制剂治疗可改善 CST 后移植物功能丧失、肾小管损伤和免疫反应。体外实验显示,在存在 miR-199a-5p 模拟物的情况下,ATP 耗竭和再补充模型中会加剧线粒体功能障碍,而应用 miR-199a-5p 抑制剂时则会减轻功能障碍。双荧光素酶测定显示 miR-199a-5p 靶向 A-激酶锚定蛋白 1(AKAP1),miR-199a-5p 激活降低了动力相关蛋白 1(Drp1)-s637 磷酸化和线粒体长度。AKAP1 的过表达可保持 Drp1-s637 磷酸化并减少线粒体分裂。miR-199a-5p 的激活降低了 AKAP1 的表达,促进了 Drp1-s637 的去磷酸化,加剧了线粒体动力学的破坏,并导致肾 IRI。这项研究通过小鼠模型和人类延迟移植物功能的 microRNA 测序确定了 miR-199a-5p 作为肾缺血再灌注损伤的关键调节因子。miR-199a-5p 通过加重移植物功能障碍、肾小管损伤和免疫反应来加重肾 IRI,而其抑制作用则具有保护作用。miR-199a-5p 下调 A-激酶锚定蛋白 1(AKAP1),降低动力相关蛋白 1(Drp1)-s637 磷酸化,增加线粒体分裂,导致功能障碍。靶向 miR-199a-5p/AKAP1/Drp1 轴为肾 IRI 提供了治疗潜力,因为 AKAP1 的过表达通过维持 Drp1-s637 磷酸化来保持线粒体完整性。